News

The effects of COVID-19 continue to reverberate in the cancer risk factors of Americans, a new American Cancer Society study ...
Royal Navy warship HMS Prince of Wales sets sail for Indo-Pacific CNN Anchor Keeps Reporting as 6.2-Magnitude Earthquake ...
“Unfortunately, Alabama is significantly higher in both cervical cancer incidence and mortality rates when compared to the U.S. Fortunately, HPV vaccination can eliminate the vast majority of cervical ...
In a groundbreaking study, the introduction of an AI-driven chatbot aimed at educating parents about the HPV vaccine has demonstrated a significant increase in vaccination rates and enhanced ...
The first trial of an AI (Artificial Intelligence)-powered chatbot designed to inform parents about the HPV ... vaccine uptake and engagement with health professionals. Cervical cancer, caused ...
The HPV vaccine is an effective means of preventing cancers associated with the virus, which is the cause of 36,000 cancer cases each year in the US. Despite its benefits, some parents are ...
Anixa Biosciences ANIX shares gained 13% on Wednesday following the announcement that the U.S. Patent and Trademark Office has issued a new patent for its groundbreaking breast cancer vaccine ...
HPV is a very common sexually transmitted infection which also increases risk of cervical cancer. The vaccine manufactured for it can protect women from being at risk of cancer or any other infection.
This patent is part of a suite of intellectual property exclusively licensed to Anixa by Cleveland Clinic, which aims to broaden the range of immunogenic compositions in Anixa's vaccine. The patent ...
Parents are more likely to vaccinate their children against human papillomavirus (HPV) when the vaccine is presented as a way to prevent cancer, rather than solely as protection against sexually ...
Cancer vaccines have been a tantalizing idea for decades ... is currently underway testing Modi-1 in patients with HPV-negative head and neck cancer or renal cancer. Early results have been ...
The U.S. Centers for Disease Control and Prevention recommend people receive the HPV vaccine around ages 11-12 to prevent the risk of sexually transmitted diseases and multiple forms of cancer ...